APA (7th ed.) Citation

Taegtmeyer, A. B., Leuppi, J., & Kullak-Ublick, G. (2012). Roflumilast – a phosphodiesterase-4 inhibitor licensed for add-on therapy in severe COPD. SMW supporting association (Trägerverein Swiss Medical Weekly SMW).

Chicago Style (17th ed.) Citation

Taegtmeyer, Anne B., Jörg Daniel Leuppi, and Gerd Achim Kullak-Ublick. Roflumilast – a Phosphodiesterase-4 Inhibitor Licensed for Add-on Therapy in Severe COPD. SMW supporting association (Trägerverein Swiss Medical Weekly SMW), 2012.

MLA (9th ed.) Citation

Taegtmeyer, Anne B., et al. Roflumilast – a Phosphodiesterase-4 Inhibitor Licensed for Add-on Therapy in Severe COPD. SMW supporting association (Trägerverein Swiss Medical Weekly SMW), 2012.